1995
DOI: 10.1016/0029-7844(95)00285-y
|View full text |Cite
|
Sign up to set email alerts
|

Malignant mixed mesodermal tumors of the ovary

Abstract: Further investigation is needed to determine the proper management for malignant mixed mesodermal tumors of the ovary. Meanwhile, current treatment strategies should recognize the present therapeutic limitations, so as not to diminish any further the quality of life for women with this malignancy.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
10
0

Year Published

1997
1997
2015
2015

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 21 publications
(11 citation statements)
references
References 8 publications
1
10
0
Order By: Relevance
“…2,7,12 Further prognostic factors for OS, such as age and depth of myometrial invasion have been previously described. 10,26 Median age of 69 years in our study (menopausal women) was however coherent with the literature, 1,4,11,12,35,36 (25) and myometrial invasion was a significant prognostic factor in the univariate analysis. Differences may be partially explained by the surgical procedures employed in our data set of patients.…”
Section: Discussionsupporting
confidence: 86%
“…2,7,12 Further prognostic factors for OS, such as age and depth of myometrial invasion have been previously described. 10,26 Median age of 69 years in our study (menopausal women) was however coherent with the literature, 1,4,11,12,35,36 (25) and myometrial invasion was a significant prognostic factor in the univariate analysis. Differences may be partially explained by the surgical procedures employed in our data set of patients.…”
Section: Discussionsupporting
confidence: 86%
“…It is highly aggressive and rapidly progressive with a poor long‐term prognosis. The median survival rate of the patients was only 7–13 months with more than 70% of the patients dying of the disease at 1 year after diagnosis 2–4 . Prognostic factors that influence the clinical outcome remain controversial due to the rarity of this tumour.…”
Section: Introductionmentioning
confidence: 99%
“…The nosological concept is equally debated between various authors. These tumors have received a variety of appellations, such as mixed mullerian (mesodermal) tumors when seen in the female genital tract, 7,8 but carcinosarcomas when they occur in the lung, liver or prostate. [9][10][11] Neoplasms of the breast that are identical to these tumors are not usually designated as carcinosarcomas, but rather are referred to as metaplastic carcinomas.…”
Section: Discussionmentioning
confidence: 99%